Linear growth in patients with hypophosphatemic vitamin D-resistant rickets: Influence of treatment regimen and parental height
- 1 March 1990
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 116 (3) , 365-371
- https://doi.org/10.1016/s0022-3476(05)82822-7
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Nephrocalcinosis and its relationship to treatment of hereditary ricketsThe Journal of Pediatrics, 1987
- Elevated Plasma 1,25-Dihydroxyvitamin D Concentrations in Infants with Hypercalcemia and an Elfin FaciesNew England Journal of Medicine, 1985
- Long-term treatment of familial hypophosphatemic rickets with oral phosphate and 1α-hydroxyvitamin D3The Journal of Pediatrics, 1981
- Bone Response to Phosphate Salts, Ergocalciferol, and Calcitriol in Hypophosphatemic Vitamin D-Resistant RicketsNew England Journal of Medicine, 1980
- Treatment of hypophosphataemic vitamin D-resistant rickets with massive doses of 1 alpha-hydroxy-vitamin D3 during childhood.Archives of Disease in Childhood, 1980
- Serum 1,25-Dihydroxyvitamin D Levels in Normal Subjects and in Patients with Hereditary Rickets or Bone DiseaseNew England Journal of Medicine, 1978
- Lesion of the Bone Matrix in Vitamin D-resistant RicketsNature, 1965
- A Unique Histological Feature of Vitamin D Resistant Rickets Observed in Four CasesActa Orthopaedica, 1963
- RADIOGRAPHIC ATLAS OF SKELETAL DEVELOPMENT OF THE HAND AND WRISTThe Lancet Healthy Longevity, 1959
- Tables for predicting adult height from skeletal age: Revised for use with the greulich-pyle hand standardsThe Journal of Pediatrics, 1952